Compounds > rofecoxib
Page last updated: 2024-11-04

rofecoxib and Uterine Cervical Dysplasia

rofecoxib has been researched along with Uterine Cervical Dysplasia in 3 studies

Uterine Cervical Dysplasia: Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grabosch, SM2
Shariff, OM2
Helm, CW2
Wulff, JL1
Hefler, LA1
Grimm, C1
Speiser, P1
Sliutz, G1
Reinthaller, A1

Reviews

2 reviews available for rofecoxib and Uterine Cervical Dysplasia

ArticleYear
Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.
    The Cochrane database of systematic reviews, 2018, 02-12, Volume: 2

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 In

2018
Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.
    The Cochrane database of systematic reviews, 2014, Apr-09, Issue:4

    Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitor

2014

Trials

1 trial available for rofecoxib and Uterine Cervical Dysplasia

ArticleYear
The cyclooxygenase-2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II-III A phase II trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2006, Apr-01, Volume: 125, Issue:2

    Topics: Adult; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Lactones; Prospective Studi

2006